Lexeo Therapeutics’ Stock Volatility Highlights Challenges and Potential in Gene Therapy Innovation
Lexeo Therapeutics Inc, a clinical-stage gene therapy biotech company, is navigating financial turbulence while pushing the boundaries of innovation in the gene therapy arena.
3 minutes to read